2 New Cases of Vaping-Related Disease Confirmed in Washington
Reported by KOMO News Monday, September 16th 2019
OLYMPIA, Wash. - Two new cases of severe vaping-related lung disease have been confirmed in Washington state, health officials said Monday.
The two new cases, both in Spokane County, are a teenager and a patient in his or her 20s, according to the officials with the state Department of Health.
Additional critical facts from the article:
Nationwide, more than 450 people have been diagnosed with severe vaping-related lung illness, and at least six of them have died, according to the Centers for Disease Control and Prevention.
Serious lung illness has been reported in people who use a variety of e-cigarette and vape devices and products, including THC- and CBD-containing products as well as nicotine-containing products. The cause or causes of this outbreak remain unknown at this time.
The CDC classifies this as an “outbreak” of severe lung disease and continues to investigate a potential common cause or causes. It creates a “case definition” to identify confirmed and probable cases common to vaping lung illness, including this important information:
All patients have a reported history of e-cigarette product use, and no consistent evidence of an infectious etiology has been discovered. Therefore, the suspected cause is a chemical exposure. The type, extent, and severity of any chemical-related illness might depend on multiple factors including the chemical to which the user was exposed; chemical changes associated with heating, dose, frequency, and duration of exposure; product delivery methods; and behaviors and medical conditions of the user. The specific behaviors and exposures of identified patients have varied. Most have reported a history of using e-cigarette products containing cannabinoids such as THC, some have reported the use of e-cigarette products containing only nicotine, and others have reported using both. No consistent e-cigarette product, substance, or additive has been identified in all cases, nor has any one product or substance been conclusively linked to pulmonary disease in patients.